Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (231-240 of 404) with videos related to

Pageof 41
Sort By:
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
The International Journal on Drug Policy|March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot StudyJason Grebely, Rosie Gilliver, Tony McNaughton, et al.
The International Journal on Drug Policy|February 9, 2019
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapyJason Grebely, Gregory J Dore, Negar N Alami, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage StudyQinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Hepatology (Baltimore, Md.)|October 26, 2019
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral InfectionMarianne Martinello, Chloe Orkin, Graham Cooke, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
Gastroenterology|December 8, 2009
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistanceKerry-Lee Milner, David van der Poorten, Michael Trenell, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
AIDS (London, England)|August 11, 2007
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individualsPeter A Revill, Margaret Littlejohn, Anna Ayres, et al.
Pageof 41

Showing results (231-240 of 404) with videos related to

Sort By:
Pageof 41
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
The International Journal on Drug Policy|March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot StudyJason Grebely, Rosie Gilliver, Tony McNaughton, et al.
The International Journal on Drug Policy|February 9, 2019
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapyJason Grebely, Gregory J Dore, Negar N Alami, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage StudyQinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Hepatology (Baltimore, Md.)|October 26, 2019
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral InfectionMarianne Martinello, Chloe Orkin, Graham Cooke, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
Gastroenterology|December 8, 2009
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistanceKerry-Lee Milner, David van der Poorten, Michael Trenell, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
AIDS (London, England)|August 11, 2007
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individualsPeter A Revill, Margaret Littlejohn, Anna Ayres, et al.
Pageof 41